Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
about
Novel immunotherapies for hematologic malignanciesAblation of a specific cell population by the replacement of a uniquely expressed gene with a toxin gene.Complete suppression of in vivo growth of human leukemia cells by specific immunotoxins: nude mouse models.Harnessing gene conversion in chicken B cells to create a human antibody sequence repertoire.Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients.Mechanisms of tumour cell escape encountered in treating lymphocytic leukaemia with anti-idiotypic antibodyCapacity of influenza virus-monoclonal antibody mixtures to stimulate memory and cytotoxic T lymphocyte populations.Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4.Use of antibodies and immunoconjugates for the therapy of more accessible cancers.Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.Experimental tumoricidal effects of monoclonal antibody against solid breast tumors.Modified immunocytochemical slide technique for demonstrating surface antigens on viable cells.The Gordon Wilson lecture. Monoclonal antibodies in human cancer.Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets.Emergence of immunoglobulin variants following treatment of a B cell leukemia with an immunotoxin composed of antiidiotypic antibody and saporin.2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USA.Tolerance to rat monoclonal antibodies. Implications for serotherapy.
P2860
Q27004436-450CE1AD-CCCB-4B45-ADE2-703254158C84Q30748534-1B79ED0D-157F-4115-8596-E496ACD0094BQ34624590-2B4F28F0-FE8A-4045-8D45-DCCD83D7AEFBQ35053450-D3255EE5-F4AD-4B65-A9DA-9083EE71617FQ35304730-C918E40A-CF82-4085-A815-99492BF04294Q35991384-FBA83566-19A2-4281-808F-FDCD874C68E9Q36337760-12CB5AFB-3497-4FDA-83FA-97F547A01176Q36352864-552C4670-B422-4AC0-950F-F7C96FF7A670Q37174938-909AB720-F31C-4846-9F95-58CF8391D2AEQ37348039-F6408CB8-3B9E-4028-8802-F827053F9C5CQ37509908-E0E5AB7E-A1EB-4CFB-AAE8-087FCBC4A487Q39545159-1D644A61-A1CA-4869-82FF-02D0DEEE65FCQ41779247-2C8F947B-A7C3-47FC-B610-98ED16526616Q41885910-AFC85490-123F-43C5-8034-1ECBE4AB3CDBQ41961674-3707BB5B-D678-4A1F-86A1-09C2C705E319Q42333514-74198ADD-A878-432F-A6FF-3AC2724B6C40Q42938072-536676F2-6BF6-4F2E-AB3D-A5E5AC327417
P2860
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
description
1982 nî lūn-bûn
@nan
1982 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
@ast
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
@en
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
@nl
type
label
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
@ast
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
@en
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
@nl
prefLabel
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
@ast
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
@en
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
@nl
P1433
P1476
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
@en
P2093
S F Schlossman
P407
P577
1982-01-01T00:00:00Z